190 related articles for article (PubMed ID: 33085048)
21. Effect of endostatin on proliferation, invasion and epithelial-mesenchymal transition of basal cell carcinoma cell A431.
Hu P; Ma L; Wu ZQ; Zheng GY; Li JT
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):877-884. PubMed ID: 30720196
[TBL] [Abstract][Full Text] [Related]
22. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.
Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H
Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404
[TBL] [Abstract][Full Text] [Related]
23. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
24. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
25. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
Liu X; Sun Z; Deng J; Liu J; Ma K; Si Y; Zhang T; Feng T; Liu Y; Tan Y
Int J Oncol; 2018 Sep; 53(3):1279-1288. PubMed ID: 29956727
[TBL] [Abstract][Full Text] [Related]
26. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV
J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102
[TBL] [Abstract][Full Text] [Related]
27. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
29. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
Jägle S; Dertmann A; Schrempp M; Hecht A
Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
[TBL] [Abstract][Full Text] [Related]
31. α-Solanine inhibits invasion of human prostate cancer cell by suppressing epithelial-mesenchymal transition and MMPs expression.
Shen KH; Liao AC; Hung JH; Lee WJ; Hu KC; Lin PT; Liao RF; Chen PS
Molecules; 2014 Aug; 19(8):11896-914. PubMed ID: 25116803
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi JP; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
PLoS One; 2010 May; 5(5):e10431. PubMed ID: 20454659
[TBL] [Abstract][Full Text] [Related]
33. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells.
Jahani M; Khanahmad H; Nikpour P
J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111
[TBL] [Abstract][Full Text] [Related]
35. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH
World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072
[TBL] [Abstract][Full Text] [Related]
36. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures.
Essid N; Chambard JC; Elgaaïed AB
Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250
[TBL] [Abstract][Full Text] [Related]
37. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer.
Murai T; Yamada S; Fuchs BC; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2014 Jun; 109(7):684-9. PubMed ID: 24453058
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]